Recent Postings to


Worst Pills, Best Pills Newsletter Articles

  View the entire September 2016 issue in PDF format

  • A Price-Gouging, Tax-Dodging Drug Company
    (September 2016)
    Find out which leading drugmaker has reaped billions of dollars in profits in the U.S. by charging unaffordable prices for its hepatitis C drugs, then shifting those profits offshore, enabling it to dodge nearly $10 billion in U.S. taxes.
  • New Gout Drug Lesinurad (ZURAMPIC) Too Dangerous
    (September 2016)
    The FDA's approval of lesinurad despite serious safety concerns and limited evidence of benefits represents another example of the agency's reckless approach to the oversight of prescription drugs. Read our independent analysis of the data considered by the FDA when it approved this new gout drug and our assessment of why you should not use it.
  • Gabapentin and the Criminal Manipulation of Science, a Decade Later
    (September 2016)
    In 2004, Parke-Davis, the manufacturer of gabapentin (NEURONTIN), pleaded guilty to felony charges for illegal marketing of the drug, including for "off-label" uses not approved by the FDA. Protect yourself and your loved ones from unnecessary risk by learning which claims about gabapentin are supported by sound science and which are not.
  • Questions & Answers
    (September 2016)
    In this month Questions & Answers section, we offer advice on how readers can approach their doctors about medicines that we have designated as either Do Not Use or Do Not Use for Seven Years.
  • Opioids and Benzodiazepines: A Deadly Combination
    (September 2016)
    Readers of Worst Pills, Best Pills News are aware that all benzodiazepine tranquilizers and sleeping pills, except for alprazolam (XANAX) and clonazepam (KLONOPIN), are now considered Do Not Use drugs. In this article, we explain why combining these drugs with opioid painkillers could kill you.
  • Do NOT ‘Go With the Flow’ for Dabigatran (PRADAXA)!
    (September 2016)
    Dabigatran is one of several new, heavily promoted anticoagulant drugs (blood thinners) approved by the FDA in recent years. Learn why you should ignore the television ads and not use this dangerous drug.

  View the entire August 2016 issue in PDF format

  • Doctors Accepting Bribes, Betraying Patients
    (August 2016)
    Worst Pills, Best Pills News editor Dr. Michael Carome discusses the recent arrest of two former drug company employees for allegedly running a brazen scheme to bribe doctors to prescribe millions of dollars' worth of a powerful synthetic opioid.
  • Incretin-Mimetic Drugs: Do Not Use to Treat Diabetes
    (August 2016)
    Incretin mimetics, one of the newer classes of diabetes drugs, are widely prescribed in the U.S. Find out why Public Citizen's Health Research Group recommends against using any of these medications.
  • Starting Beta Blockers Before Noncardiac Surgery May Be Harmful
    (August 2016)
    Beta blockers, which are widely used and effective in treating high blood pressure, heart disease and heart failure, are often started in patients prior to surgery in an effort to prevent cardiovascular complications. Learn why starting beta blockers immediately before undergoing surgery may be dangerous.
  • Proton Pump Inhibitors Linked to Dementia in the Elderly
    (August 2016)
    In this article, we review new research linking use of the heartburn and ulcer medications known as proton pump inhibitors to an increased risk of dementia.
  • Supplements for Age-Related Macular Degeneration
    (August 2016)
    Numerous high-dose dietary supplements are now broadly marketed to promote general eye health. Find out who can benefit from — and who should not take — these supplements and which ingredients to look for on the label.
  • News Brief for August 2016
    (August 2016)
    In this month's news briefs, we report on the FDA's decision to require new black-box warnings in the labeling of all immediate-release opioid drugs about the risks of abuse, addiction, overdose and death, as well as the agency's recent drug safety alert reminding consumers not to purchase over-the-counter chelation products. We also discuss the decision of a major drugmaker to terminate its involvement in the marketing of an inhaled form of insulin.

  View the entire July 2016 issue in PDF format

  • Proton Pump Inhibitors Might Cause Chronic Kidney Disease
    (July 2016)
    Public Citizen's Health Research Group has long warned about the serious risks of the commonly used group of heartburn drugs known as proton pump inhibitors. In this article, we discuss new research suggesting that chronic kidney disease is another potential side effect of these drugs.
  • Antibiotic Misuse: Dangerous for Everyone
    (July 2016)
    When health care providers prescribe antibiotics to patients who do not need them, these drugs endanger both the patients taking them and the public at large. Find out why.
  • Vitamin D for Preventing Falls in the Elderly: Less Is Safer
    (July 2016)
    Many people take vitamin supplements to promote bone and muscle health. But taking too much vitamin D may have dangerous consequences. Read this article to find out how much vitamin D is safe.
  • Drugs That Cause Sun-Related Skin Reactions
    (July 2016)
    Summer is a terrific time for healthy outdoor activities, such as walking, hiking, biking and swim¬ming. But for an unlucky few, certain medications can lead to adverse skin reactions following exposure to the sun. Find out whether you are at risk and how to protect yourself.
  • Drug-Induced Hair Loss
    (July 2016)
    For most people with hair loss, the condition usually is age-related or due to the genes they inherited from their parents. But for some patients, the cause of the problem can be found in the medicine cabinet. Learn about some commonly used medications that can cause hair loss.

Additional Information from Public Citizen

Copyright © 2016 Public Citizen's Health Research Group. All rights reserved.